J Hunter Mehaffey1, Alex D Michaels1, Mathew G Mullen1, Max O Meneveau1, John R Pender2, Peter T Hallowell3. 1. Department of Surgery, University of Virginia, Charlottesville, Virginia. 2. Department of Surgery, Billings Clinic, Billings, Montana. 3. Department of Surgery, University of Virginia, Charlottesville, Virginia. Electronic address: PTH2F@virginia.edu.
Abstract
BACKGROUND: Increasingly, patients are faced with greater travel distances to undergo bariatric surgery at high-volume centers. OBJECTIVES: This study sought to evaluate the impact of travel distance on access to care and outcomes after bariatric surgery. SETTING: Patients who underwent Roux-en-Y gastric bypass at an academic bariatric surgery center from 1985 to 2004 were examined and stratified by patient travel distance. METHODS: Univariate analyses were performed for preoperative risk factors, 30-day complications, and long-term (10-yr) weight loss between "local," defined as<1 hour of travel time, and "regional," defined as>1 hour of travel time. Survival analysis was performed with Kaplan-Meier and Cox proportional hazards models. RESULTS: A total of 650 patients underwent Roux-en-Y gastric bypass, of whom 316 (48.6%) traveled<1 hour to undergo surgery and 334 (51.4%) traveled>1 hour. Median body mass index was equivalent between the groups (local, 52.9 kg/m2; regional, 53.2 kg/m2; P = .76). Patients who traveled longer distances had higher rates of preoperative co-morbidities, including chronic obstructive pulmonary disease, congestive heart failure, diabetes, and sleep apnea (all P<.05). Complications within 30 days of surgery and long-term reduction of excess body mass index were equivalent between groups. Travel time was an independent predictor of risk-adjusted reduced long-term survival (hazard ratio, 1.23, P = .0002). CONCLUSIONS: A majority of patients who underwent bariatric surgery at our center traveled>1 hour. Despite longer travel time for care, 30-day complications and long-term weight loss were equivalent with that of local patients. As expected, patients who lived in close proximity were more likely to adhere to yearly follow-up in surgery clinic. Travel time was an independent predictor of risk-adjusted reduced long-term survival.
BACKGROUND: Increasingly, patients are faced with greater travel distances to undergo bariatric surgery at high-volume centers. OBJECTIVES: This study sought to evaluate the impact of travel distance on access to care and outcomes after bariatric surgery. SETTING:Patients who underwent Roux-en-Y gastric bypass at an academic bariatric surgery center from 1985 to 2004 were examined and stratified by patient travel distance. METHODS: Univariate analyses were performed for preoperative risk factors, 30-day complications, and long-term (10-yr) weight loss between "local," defined as<1 hour of travel time, and "regional," defined as>1 hour of travel time. Survival analysis was performed with Kaplan-Meier and Cox proportional hazards models. RESULTS: A total of 650 patients underwent Roux-en-Y gastric bypass, of whom 316 (48.6%) traveled<1 hour to undergo surgery and 334 (51.4%) traveled>1 hour. Median body mass index was equivalent between the groups (local, 52.9 kg/m2; regional, 53.2 kg/m2; P = .76). Patients who traveled longer distances had higher rates of preoperative co-morbidities, including chronic obstructive pulmonary disease, congestive heart failure, diabetes, and sleep apnea (all P<.05). Complications within 30 days of surgery and long-term reduction of excess body mass index were equivalent between groups. Travel time was an independent predictor of risk-adjusted reduced long-term survival (hazard ratio, 1.23, P = .0002). CONCLUSIONS: A majority of patients who underwent bariatric surgery at our center traveled>1 hour. Despite longer travel time for care, 30-day complications and long-term weight loss were equivalent with that of local patients. As expected, patients who lived in close proximity were more likely to adhere to yearly follow-up in surgery clinic. Travel time was an independent predictor of risk-adjusted reduced long-term survival.
Authors: Xiang Yuan; Lisa R Martin Hawver; Peter Ojo; Luke M Wolfe; Jill G Meador; John M Kellum; James W Maher Journal: Surg Obes Relat Dis Date: 2008-08-30 Impact factor: 4.734
Authors: J Hunter Mehaffey; Damien J LaPar; Florence E Turrentine; Michael S Miller; Peter T Hallowell; Bruce D Schirmer Journal: Surg Obes Relat Dis Date: 2014-12-08 Impact factor: 4.734
Authors: Ryan C Broderick; Hans F Fuchs; Cristina R Harnsberger; David C Chang; Bryan J Sandler; Garth R Jacobsen; Santiago Horgan Journal: Obes Surg Date: 2015-12 Impact factor: 4.129
Authors: Junun Bae; Jaime Shade; Amanda Abraham; Brianna Abraham; Leigh Peterson; Eric B Schneider; Thomas H Magnuson; Michael A Schweitzer; Kimberly E Steele Journal: JAMA Surg Date: 2015-07 Impact factor: 14.766
Authors: Laura Pestana; James Swain; Ross Dierkhising; Michael L Kendrick; Patrick S Kamath; Kymberly D Watt Journal: Mayo Clin Proc Date: 2015-02 Impact factor: 7.616
Authors: Nicole M Gilbertson; Julian M Gaitán; Victoria Osinski; Elizabeth A Rexrode; James C Garmey; J Hunter Mehaffey; Taryn E Hassinger; Sibylle Kranz; Coleen A McNamara; Arthur Weltman; Peter T Hallowell; Steven K Malin Journal: PLoS One Date: 2020-10-02 Impact factor: 3.240
Authors: Robert B Hawkins; Matthew Byler; Clifford Fonner; Irving L Kron; Leora T Yarboro; Alan M Speir; Mohammed A Quader; Gorav Ailawadi; J Hunter Mehaffey Journal: J Card Surg Date: 2019-08-02 Impact factor: 1.620